Morgan Stanley Issues Positive Forecast for Envista (NYSE:NVST) Stock Price

Envista (NYSE:NVST) had its price target upped by Morgan Stanley from $19.00 to $20.00 in a report published on Thursday,Benzinga reports. The brokerage currently has an equal weight rating on the stock.

Several other analysts also recently commented on the company. Robert W. Baird raised their price objective on Envista from $17.00 to $22.00 and gave the stock a “neutral” rating in a research note on Thursday, October 31st. Jefferies Financial Group raised their price objective on Envista from $20.00 to $22.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Stifel Nicolaus raised their price objective on Envista from $18.00 to $21.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Mizuho assumed coverage on Envista in a research note on Wednesday, December 4th. They set an “underperform” rating and a $20.00 price objective on the stock. Finally, Leerink Partnrs raised Envista from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 31st. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $20.21.

Envista Stock Performance

NVST stock opened at $21.76 on Thursday. The business’s fifty day moving average is $19.97 and its 200-day moving average is $19.10. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.08 and a quick ratio of 1.77. Envista has a twelve month low of $15.15 and a twelve month high of $24.79.

Envista (NYSE:NVST) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.24 earnings per share for the quarter, beating analysts’ consensus estimates of $0.23 by $0.01. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. Research analysts predict that Envista will post 0.72 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Envista

Hedge funds have recently modified their holdings of the stock. Pacer Advisors Inc. grew its holdings in shares of Envista by 22.2% in the 3rd quarter. Pacer Advisors Inc. now owns 3,529,827 shares of the company’s stock valued at $69,749,000 after acquiring an additional 642,401 shares in the last quarter. Diamond Hill Capital Management Inc. grew its holdings in shares of Envista by 8.1% in the 3rd quarter. Diamond Hill Capital Management Inc. now owns 1,335,710 shares of the company’s stock valued at $26,394,000 after acquiring an additional 100,360 shares in the last quarter. Harbor Capital Advisors Inc. grew its holdings in shares of Envista by 138.5% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 404,589 shares of the company’s stock valued at $7,995,000 after acquiring an additional 234,941 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. bought a new position in shares of Envista in the 4th quarter valued at about $53,000. Finally, Hotchkis & Wiley Capital Management LLC bought a new position in shares of Envista in the 3rd quarter valued at about $14,965,000.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.